PRESENTATION

FY2023 — Results presentation

FY2023PDF · 74 pages5.1 MB
AUDITED RESULTS
For the year ending 30 June 2023

-- 1 of 74 --

2
Normalised
operating profit
+24%
to R11 661m
Normalised
headline earnings
+32%
to R7 678m
Headline
earnings
+5%
to R5 490m
Core new
business
+12%
to R22 788m
Excluding discontinued products
like VitalityInvest and Ping An Health
reinsurance business
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health
Vitality Health	
Vitality Life
USA

-- 2 of 74 --

3
1
2
3
Growing quality earnings with a robust
balance sheet
A clear strategy per composite, intensifying
focus on key initiatives and ceasing those with
marginal benefits
4
+12%
New business
64%Cash
conversion
+24%Operating
profit
20%
FLR
10.6%
Investment in New
excl discontinued UK
Transitioning to IFRS 17
Evolving the Vitality Shared-Value Insurance
Model

-- 3 of 74 --

4
0%
20%
40%
60%
80%
100%
120%
140%
New
business
Lapses Claims
SA composite
UK composite
Group average
Projections
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
2021 2022 2023 2024
World
South Africa
United Kingdom
United States
China
1 Source: International Monetary Fund, World Economic Outlook, July 2023 Update
2 Sources: US Bureau of Labour statistics, StatsSA, Statista, Office for National Statistics
3 Source: Bank for International Settlements
Central bankers remaining cautious
despite inflation cooling globally
Actuarial dynamics
remain robust
Global growth
under pressure
Real GDP growth1
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
Jan-21	
May-21	
Sep-21	
Jan-22	
May-22	
Sep-22	
Jan-23	
May-23
South Africa
United Kingdom
United States
China
-2%
0%
2%
4%
6%
8%
10%
12%
Jan-21	
May-21	
Sep-21	
Jan-22	
May-22	
Sep-22	
Jan-23	
May-23
United States
South Africa
China
United Kingdom
CPI inflation rates2 Central bank policy
rates3
Volatile exchange
rates
80
85
90
95
100
105
110
115
120
125
130
Jan-2022	
Mar-2022	
May-2022
Jul-2022	
Sep-2022	
Nov-2022	
Jan-2023	
Mar-2023	
May-2023
USDZAR GBPZAR
USD/ZAR and GBP/ZAR
exchange rates
New business (YoY),
claims and lapses AvE

-- 4 of 74 --

5
Health 3 854 +7% 8 678 +19% 1 201 +10%
Life 4 807 +19% 2 838 +12%
Invest 1 560 +30% 3 050 +4%
Insure 62 +138% 1 249 +0%
Bank -767 -23% 1 517 +60%
Other SA initiatives -312 +28% 631 -25%
Central costs -124 n/a
SA 9 096 +22% 16 818 +11% 2 718 +33%
VitalityHealth 1 283 -3% 2 064 +19%
VitalityLife 1 039 +55% 1 721 +37%
Closure costs of Vitality Invest and Vitality Car -455 -0%
Other initiatives and central costs -79 +32%
UK 1 788 +21% 3 785 +26%
Vitality Network 411 +26% 2 2223 +59%
VHI - Other -195 +1%
VHI - Ping An Health Insurance 596 +76% 2 1852 -1%
Other initiatives and central costs -35 +46%
Vitality Global 777 +74% 2 185 -1% 2 2223 +59%
Operating profit New business1
2 PAHI own licence
+24%
R11 661m +12%
R22 788m
1 Excl products in run down
Non-insurance income
+44%
R4 940m
ZARm
3 VG income excludes cost recoveries and rewards

-- 5 of 74 --

6
Operating profit Core new business API Total income from non-insurance
business lines
-
1,000
2,000
3,000
4,000
5,000
FY19 FY20 FY21 FY22 FY23
R4 940m	R11 661m R22 788m
-
2,000
4,000
6,000
8,000
10,000
12,000
-
2,500
5,000
7,500
10,000
12,500
15,000
17,500
20,000
22,500
New COVID-19 COVID-19

-- 6 of 74 --

7
Decreased investment in New Initiatives Going forward
• Discovery Bank due to reach operational
break-even in FY24
• Africa Health merged into Discovery Health
to provide focused health expertise to
multinational clients in Africa
• Umbrella Funds to be absorbed into a
focused Corporate and Employee Benefits
business unit
• Vitality1 to be folded into Vitality Global
• Vitality Invest to be closed by end of CY23
• Vitality Health International a key expansion
strategy for Vitality Global
0%
5%
10%
15%
20%
25%
2017 2018 2019 2020 2021 2022 2023
Investment in New Initiatives (%)
1 VitalityInvest and VitalityCar write-down
Discontinued
UK businesses1
10.6%
13.6% incl. discontinued UK initiatives
10% target

-- 7 of 74 --

8
Opening EV Value of new
business
Unwind of risk
discount rate
Non-economic
experience
variances and
methodology &
assumption
changes
Operational EV Economic
experience
variances and
methodology &
assumption
changes
Forex New Initiatives Other Closing EV
R98 176m
R98 711m
R86 258m
Operational EV Economic and other
Economically
driven
Positive non-
economic experience
variances (Rm)
Health1 703
Life 521
VitalityHealth 555
VitalityLife 819
Total 2 598
Positive
variances 13.2% RoEV
1 Health and Vitality

-- 8 of 74 --

9
1 Considers cash at centre, Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank
2 Capital Adequacy Ratio
3 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission
4 Centre cash + undrawn committed facilities
Highly liquid across the
Group FLR within target Sufficient liquidity	Strongly capitalised
DHMS solvency
(unaudited)
30.2%
Jun 22
Cover
Jun 23
Cover
Life 1.7x 1.9x
Insure 1.2x 1.6x
VH 1.5x 1.4x
VL 2.1x 2.1x
Bank2 1.3x 1.3x
PAHI3 2.8x 2.7x
14%
16%
18%
20%
22%
24%
26%
28%
30%
FY17 FY18 FY19 FY20 FY21 FY22 FY23
FLR
20.4%
28%
Centre liquidity4 , R millions
-
500
1,000
1,500
2,000
2,500
3,000
FY18 FY19 FY20 FY21 FY22 FY23
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
FY19 FY20 FY21 FY22 FY23
Liquid assets across the Group1,
R millions
64% Cash
conversion

-- 9 of 74 --

10
Rm
12 months
ended
Jun 2022
12 months
ended
Jun 2023
%
Normalised profit from operations before economic assumptions
adjustments 9 384 11 661 +24%
Economic assumptions adjustment DL -651 -2 811
Economic assumptions adjustment VL 567 147
Time value of swaption -454 -204
Investment income and fair value gains on financial instruments 219 538
Finance charges excl. 1DP finance lease -1 385 -1 664
Vaccination costs -157 -
Other (including IFRS reporting adjustments) -254 -277
Profit before tax 7 269 7 390 +2%
Tax -1 790 -2 070
Profit not attributable to ordinary shareholders -57 -152
Loss on impairment and derecognition 44 302
Other headline earnings adjustments -262 20
Headline earnings 5 204 5 490 +5%
Economic assumptions adjustment (DL and VL) after tax and hedging 10 1 936
Other 602 252
Normalised headline earnings 5 816 7 678 +32%
1
2
1
The sharp rise in both nominal
and real interest rates in SA
resulted in Discovery Life
economic assumptions
adjustments of R2 811 million
2
Lower effective tax rate in prior
year with a significant driver
being the DTA adjustment
arising from a decrease in SA
corporate tax rate to 27%

-- 10 of 74 --

11
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
3.5%
4.0%
4.5%
5.0%
Jan
2016
Jan
2017
Jan
2018
Jan
2019
Jan
2020
Jan
2021
Jan
2022
Jan
2023
First hedge
and swaption
purchased
Hedges
moved onto
PAC book
Hedge
strategy
simplified
0%
1%
2%
3%
4%
5%
6%
1
16
31
46
61
76
91
106
121
136
151
166
181
196
211
226
241
256
271
286
By duration
Jun 19 Jun 22 Jun 23
Nominal rate curve
Real rate curve
4%
6%
8%
10%
12%
14%
16%
1
16
31
46
61
76
91
106
121
136
151
166
181
196
211
226
241
256
271
286
By duration
Jun 19 Jun 22 Jun 23
Significant movements in SA yield curves
impacted Discovery Life earnings
UK hedging strategy led to lower IFRS 4
earnings volatility in VitalityLife
Under IFRS 17, OCI will reduce the volatility of IFRS earnings and effectively amortise changes over time
-4,000
-3,500
-3,000
-2,500
-2,000
-1,500
-1,000
-500
0
500
FY20 FY21 FY22 FY23
-4,000
-3,500
-3,000
-2,500
-2,000
-1,500
-1,000
-500
0
500
FY20 FY21 FY22 FY23
Economic assumptions
adjustments (Rm)1
Economic assumptions
adjustments (Rm)1
UK 25-year SONIA rate
1 Economic assumptions adjustments before tax, net of VL hedging impacts

-- 11 of 74 --

12
Dividend declaration of 110cps in respect of H2 FY23. In future, interim ordinary dividends are expected to
be paid in the range of 30%-40% of the expected total annual ordinary dividend, in line with market
practice, with the remainder of the dividend to be paid as a final dividend
Rm
12 months
ended
Jun 2022
12 months
ended
Jun 2023
%
Normalised profit from operations before economic assumptions
adjustments 9 384 11 661 +24%
Economic assumptions adjustment DL -651 -2 811
Economic assumptions adjustment VL 567 147
Time value of swaption -454 -204
Investment income and fair value gains on financial instruments 219 538
Finance charges excl. 1DP finance lease -1 385 -1 664
Vaccination costs -157 -
Other (including IFRS reporting adjustments) -254 -277
Profit before tax 7 269 7 390 +2%
Tax -1 790 -2 070
Profit not attributable to ordinary shareholders -57 -152
Loss on impairment and derecognition 44 302
Other headline earnings adjustments -262 20
Headline earnings 5 204 5 490 +5%
Economic assumptions adjustment (DL and VL) after tax and hedging 10 1 936
Other 602 252
Normalised headline earnings 5 816 7 678 +32%
1
2
1
The sharp rise in both nominal
and real interest rates in SA
resulted in Discovery Life
economic assumptions
adjustments of R2 811 million
2
Lower effective tax rate in prior
year with a significant driver
being the DTA adjustment
arising from a decrease in SA
corporate tax rate to 27%

-- 12 of 74 --

13
Volatility of future
earnings buffered
by CSM and the
use of OCI
Discovery’s
earnings are
approaching
cross-over
IFRS 17 margins
increase by cR15bn
with a concomitant
cR12.5bn reduction
in shareholder
equity
Value is largely
unchanged
1 2 3 4

-- 13 of 74 --

14
Main businesses Impact resulting from IFRS 17
Health Not applicable
Life (Individual) Significant
Life (Group) Minimal
Invest Significant
Insure Minimal
Bank Not applicable
VitalityHealth
Minimal
(but some impact regarding
acquisition costs)
VitalityLife Significant
VHI - Ping An Health
Insurance
Minimal
(but some impact regarding
acquisition costs)
Vitality Network Not applicable
Vitality Health
International Not applicable
No change in underlying value nor
underlying economics
• No direct change to cash flows,
underlying risk and reward of contracts.
Tax cash flow impact expected to be
immaterial
• No impact on regulatory or economic
solvency, capital position or capital
management
• Immaterial impact on Embedded Value
• Ability to pay dividend unaffected as
cash flows and solvency remain
unchanged
Accounting standard change that effects
the timing of profit recognition, therefore
affects transitional balance sheet
1
2

-- 14 of 74 --

15
Total value the same but reallocated
1
2
2
Three conceptual
value drivers
Total value the same
meaning that value
shifts between equity
and margins
BEL is similar in
nature and size to
NEFCF
Best
estimate of
future cash
flows (BEL)
Compulsory
margin
IFRS 4
Discretionary
margin
Equity of
ordinary
shareholders
IFRS 17
Net
expected
future cash
flows
(NEFCF)
Risk
adjustment
(RA)
Contractual
service
margin
(CSM)
Equity of
ordinary
shareholders
(incl OCI)
Future
cash
flows
Margins
Shareholder
equity
PV future
cashflows
PV
future
profits
PV
past
profits
Assets Margins and
equity
1

-- 15 of 74 --

16	1 Average over the past 5 years
Concentrated in long-term whole of life business
with large upfront acquisition costs Change in expense recognition and recognising
onerous contracts
IFRS 17 is much more specific on
what is non-directly attributable and
so are not offset by margins; hence
margins are preserved under IFRS 17
and released as profits later
IFRS 4 IFRS 17
Under Discovery’s application
of IFRS 4 all acquisition
expenses were included when
ensuring a zero profit on initial
recognition
Policy administration and maintenance costs
Commission payments
Underwriting costs
Claim assessment and other claim-related costs
Directly attributable allocated fixed and variable overheads
Vitality
Life
Discovery
Life
Launch 2016 2000 Relatively young life
insurance
companies
ACI increases 4-9% 11.5%1 Rapidly growing
Proportion of life
insurance business 100% 80% Mono-line
Average contract
boundary
35
years
50
years Long-term contracts
Commission as %
of first year
premium
210% 85% High upfront
acquisition costs 5%
95%
Marketing and sponsorships
Group executive and Group functions
Research and development activities of new products
Corporate initiatives
Directly attributable under IFRS 17
Non-directly attributable under IFRS 17
Discovery expenses
1
2 Under IFRS 17 onerous contracts immediately expensed,
thereby preserving margins on profitable contracts

-- 16 of 74 --

17
Simplified illustration
IFRS 4
IFRS 17
Duration
Annual p
rofit
𝑨
𝑩
Pre-cross-over Post-cross-over
Discovery’s life businesses on
transition from IFRS 4 to IFRS 17:
Annual earnings depend on
where in time the cross-over is
Margins always increase
Shareholder equity always
decreases
Earnings
Duration
Margin balance
Duration
Equity
IFRS 4
IFRS 17
IFRS 4
IFRS 17
Margin
Shareholder equity
The cross-over point is the
most optimal because
earnings would be the same,
margins would increase and
the impact on equity is at a
maximum
1
2
3
4
1
2
3
4
Layering on new business Run-off of an individual cohort

-- 17 of 74 --

18
Drivers of the margin and equity change
Total value largely unchanged
Strengthening of margins mirrored
by a reduction of equity in range of
R12bn to R13bn
(R12.5bn used in the illustration)
Total margins strengthened by
cR15bn as at 1 July 2022
Non-directly attributable expenses under
IFRS 17
Cohorting and onerous contracts:
immediate expensing of loss making
(onerous) contracts under IFRS 17
Other: impacts incl. different treatment of
basis changes and discount rates through
the margin under IFRS 17
Non-attributable
expenses:
R6.5bn
R9.0bn pre-tax
Onerous:
R3.5bn
R4.5bn pre-
tax
Other: R1.0bn
R1.5bn pre-tax
IFRS
equity
R53.5bn
Deferred tax
IFRS 4
margins
IFRS 4 IFRS 17
FY 22
EFCF diff
IFRS
equity
R41bn
RA
R10bn
CSM
R34bn
IFRS 4
IFRS 17
Duration
Annual p
rofit
Discovery Life	
Vitality Life
1 Proportion of FY22 non-directly attributable expenses to the total Discovery marketing and administration and acquisition costs for insurance business lines
2 Proportion of FY22 portfolio that is onerous
1
2
3
Group is approaching cross-over
c5% of total expenses1
onerous2	
c9% Discovery Group’s cross-over will lag
Discovery Life’s, and its earnings as a whole
under IFRS 17 are not expected to be
significantly different to the IFRS 4
normalised operating profit in the interim, as
the other businesses are largely unaffected

-- 18 of 74 --

19
Future earnings should be less volatile due to additional CSM - buffering against basis changes for
non-economic variances and a more stable release of profits. The use of OCI also buffers against
basis changes for economic variances and reclassifies to profit or loss on systematic variances
Overall, on transition to IFRS 17, Discovery is approaching the cross-over point, at which point
earnings will be at the same level as under IFRS 4, and from there should continue to grow more
strongly with the release of the additional margin over time
IFRS 17 margins will increase by cR15bn (gross of tax) and shareholder equity will reduce by a
concomitant cR12.5bn (net of tax)
The value stays largely the same
On transition to IFRS 17:

-- 19 of 74 --

20
Making people healthier1
Restoring the climate and
environment
Strengthening healthcare
system and nation building
Ensuring diverse and inclusive
workforce, leadership and
board7
Ensuring fair and responsible
pay
2
3
4
5
Focus areas and FY23 outcomes
503m (+15%) >3m (>2m) R13.7bn (+20%)
Healthy activities
recorded1
Life years saved2 Shared-value
dividend3
18.5%
Lower carbon
emissions5
Female Black
Staff +3% (65%) +5% (88%)
Leadership +0% (52%) +2% (63%)
Group Exec Committee +2% (19%) +5% (26%)
ESG Ratings Peer rating4
Highest 19.4 #1	81%
2023 2023	2023
1 Healthy activities include relevant physical activity events recorded and HealthyFood purchases; the prior year was restated to 438m to allow for duplications ; 2 Life years saved is calculated from healthy activities recorded, using the methodology in
the informed by the Habit Index; 3 Includes R6.25bn and R6.33bn Shared-value and rewards returned to customers respectively and R1.15bn DHMS dividend from Vitality; 4 Relative to domestic life insurance peer group; 5 Relative to 2019 base,
measured by Scope 1 + Scope 2 emissions, before verification ; 6 Potholes filled to date, with growth rate measured at June 2023; 7 ‘Leadership’ and ‘staff’ is for SA, with Black including AC and I; 8 Relative to SA financial services group;
4,6
Discovery Green
Renewable energy platform
launched
1
2023
B-BEE
level
Minimum pay
R180,000 threshold more than 3x
prescribed min pay in SA
Gender pay Gap
Has been closed to ~0% for
same-role size
41m (+2%)
Lives impacted
R33m Fund contribution
Essential healthcare services in
rural communities
R12m research grants
Predominantly black medical
public sector specialists
Board targets achieved
38% Black directors
38% Female directors
~190,000 (+57%)
Potholes filled through
Pothole Patrol6
2nd of 19
Lowest income disparity
ratio8
Lowest
Carbon emitter4,5

-- 20 of 74 --

21

-- 21 of 74 --

22
Provides opportunity to impact
the following key variables:
UNDERWRITING PREMIUMS CLAIMS AND
EXITS
1 2 3
Acquisition
and
Underwriting
Dynamic
Pricing
Dynamic
Risk
Assessment
Personalised
Engagement
Sales and
Retention
Data
Life Health
The rate of mortality
The cost of morbidity
The rate of lapse
The rate of upsell
Product competitiveness
and the rate of sales
𝑞𝑥
𝑠𝑥
𝑙𝑥
Valuation Models

-- 22 of 74 --

23
Behavioural data
Acquisition,
underwriting and
pricing
Traditional life insurance models
Claims
Acquisition,
underwriting
Shared-value life insurance models
Dynamic Pricing Dynamic risk
assessment
Engagement and
behaviour change Claims
1
Lifestyle data Exercise. Sleep. Nutrition. Biometrics. Alcohol
Engagement Propensity Resilience
2
Digital Data
Ingestion and
Selective Probing
Personalised Risk
Algorithm
Actuarial,
resonance and
habit optimisation
Hyper-
personalized
pathways
Next Best
Action and
incentives
Valuation module
Sales &
selection
effect
Behavioural effect
Lapse
effect
Dynamic pricing model
Wedge pricing model
Fund boost model
Differential assumptions and transitions
Archetypes
GLOBAL

-- 23 of 74 --

24
Acquisition,
underwriting
Shared-value model in health
Dynamic Risk
Assessment
Engagement and
behaviour change Claims and retention	Value based care
Joint venture developing a data science platform with AI-
driven personalised health recommendations
Africa Health
Insurance
USA
Health

-- 24 of 74 --

25
*Interim results and pathways, subject to change
Up to 40 actions for this member
Newly diagnosed Type 2 diabetic,
female, age 50, no other co-morbidities
savings per annum if all
diabetics exercise >3 times per week
Increase in physical
activity reduces
healthcare costs by
R4 200 p.a.
Regular pathology testing
(HBa1C and Lipogram)
reduces costs by
R4 000 p.a.
Adherence to chronic
medication reduces
healthcare costs by
R2 000 p.a.
Take your
medication
3 Moves
Visit your
doctor
6 Moves
Walk 10 00
steps
6 Moves
Walk
10 000
steps

-- 25 of 74 --

26
GLOBAL

-- 26 of 74 --

27
• Scaling the Bank to profit and positioning it as the face of the composite
• Ensuring each business is market leader in terms of market share, margin, product and customer value
• Scaling Ping An Health Insurance in a complex Chinese market
• Monetising and scaling IP in Vitality Network with key partners
• Globalising unique health assets
• Growing VitaltyHealth on the back of a complex NHS environment
• Using the Shared-Value Model to get superior ROC and growth in VitalityLife
• Integration of Life and Health
Perfect composite model, #1 in our chosen segments in every industry, and the Bank pivoting to growth as
the composite-maker within SA
A new generation life and health insurance composite, with integration at both a product and operational level
and a seamless One Vitality client journey
Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our
Vitality shared-value and health management capabilities to assist them in making their customers healthier,
while ensuring their products are more competitive with better margins

-- 27 of 74 --

28
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 28 of 74 --

29
Jul-19
Dec-19	
May-20	
Oct-20	
Mar-21	
Aug-21	
Jan-22	
Jun-22	
Nov-22	
Apr-23
+22%
Total
clients Advances	Net income Retail deposits Operating result
Total
accounts
-R767m
Rm
+67%
Jul-19
Dec-19	
May-20	
Oct-20	
Mar-21	
Aug-21	
Jan-22	
Jun-22	
Nov-22	
Apr-23
Jul-19
Dec-19	
May-20	
Oct-20	
Mar-21	
Aug-21	
Jan-22	
Jun-22	
Nov-22	
Apr-23
+36%	+49% +59% to R14.3bn	to >700k to 1.6m to R1.2bn to R5.2bn
-1,400
-1,200
-1,000
-800
-600
-400
-200
0
2019 2020 2021 2022 2023
New business acquisition costs
(NBAC)
Loss before NBAC
2019 2020 2021 2022 2023

-- 29 of 74 --

30
0
20
40
60
80
100
120
140
2021-Jan	
2021-Apr	
2021-Jul	
2021-Oct	
2022-Jan	
2022-Apr	
2022-Jul	
2022-Oct	
2023-Jan	
2023-Apr
NII NIR
Accelerating growth in
client base
Increasing engagement
over time
High NIR compared to
the market
Rapid growth in revenue
Average sales per work day NII and NIR per month NIR per customer	NIR by duration
0
200
400
600
800
1,000
1,200
Jan-20	
May-20	
Sep-20	
Jan-21	
May-21	
Sep-21	
Jan-22	
May-22	
Sep-22	
Jan-23	
May-23
177
0
20
40
60
80
100
120
140
160
180
200
1 2 3 4 5 6 7 8 9 10 11 12
Duration in force
55%
CAGR
1,963
1,842
1,528
1,398
1,262
536
Bank A
Discovery
Bank	
Bank B	
Bank C	
Bank D	
Bank E

-- 30 of 74 --

31
0%
1%
2%
3%
4%
5%
6%
7%
8%
9%
Jan-22	
Feb-22	
Mar-22	
Apr-22	
May-22	
Jun-22	
Jul-22
Aug-22	
Sep-22	
Oct-22	
Nov-22	
Dec-22	
Jan-23	
Feb-23	
Mar-23	
Apr-23	
May-23	
Jun-23	
Bank A	
Bank B	
Bank C	
Bank D
Superior credit quality
Stable credit losses
despite rate hikes
Expanding credit
offerings
R250bn in home loan
balances
Volume distribution
of existing accounts1
Credit loss ratio2
Q4
2023
Staff and adviser
pilot
Market launch
Market launch
Q1
2024
Q2
2024
1 Source: BA900, Transunion report
2 Including overlays and IFRS adjustments
Big 4
Discovery Bank clients’
advances as at Aug 23 (Rbn)
Discovery Bank
Market
250
346
25
48
18
23
Outstanding
balance
Limits
Home loans Credit card
Personal loans
Subprime
Near prime
Prime
Prime plus
Super prime
Subprime
Near prime
Prime
Prime plus
Super prime

-- 31 of 74 --

32
Expense efficiencies realised as
the Bank continues to scale
Operating leverage as more
products are added
Reaching breakeven earlier than
expected
-
20
40
60
80
100
120
Jan-22
Mar-22
May-22
Jul-22
Sep-22
Nov-22
Jan-23
Mar-23
May-23
Jul-23
Average net income pc Expenses pc
Expenses and income per customer Profit before new business acquisition
costs
Fixed and variable costs over time
Discovery
account
Life Bank
integrator
Share
trading
Travel in
Bank app
AR3.0 Payshap
Jul-23	
Sep-23	
Nov-23	
Jan-24	
Mar-24	
May-24
Jul-24	
Sep-24	
Nov-24	
Jan-25	
Mar-25	
May-25
Jul-25	
Sep-25	
Nov-25
February 23 expectations
Current expectations
Access
facilities
Home
loans
Jul-20	
Sep-20	
Nov-20
Jan-21	
Mar-21	
May-21
Jul-21	
Sep-21	
Nov-21	
Jan-22	
Mar-22	
May-22
Jul-22	
Sep-22	
Nov-22	
Jan-23	
Mar-23	
May-23
Fixed costs Variable costs

-- 32 of 74 --

33
Discovery portfolio is linked directly to Vitality
Health, Vitality Drive and Vitality Money
behavioural platforms
Rewards monetised in Discovery Miles Shared
Value currency
Integrated ecosystems enabled by Discovery
Bank operating system and third-party
partnerships
Banking
portfolio
Discovery
Portfolio
New lending
products
Health claim s
We have received your latest claim	
from your recent consultation w ith Dr	
Da Svel for R956.27.	
Your claim will be settled as follows:	
Total paid by MSA: R 756.17	
Total paid by HealthPay: R 200.10	
Balance owed to provider: R 0.00	
Your available balances are:	
MSA: R 15,200.32
Discov ery Bank Black Card: R 25,327.66	
Tap here to see full details
Healt h Pay Clai m s no t if icat i on
Banking portfolio
underpinned by
digital payments
capabilities

-- 33 of 74 --

34
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 34 of 74 --

35
Jan-18	
Jun-18	
Nov-18	
Apr-19	
Sep-19	
Feb-20	
Jul-20
Dec-20	
May-21	
Oct-21	
Mar-22	
Aug-22	
Jan-23	
Jun-23
Healthy Company
Gap Cover
Flexicare
1993
1995
1997	
1999	
2001	
2003	
2005	
2007	
2009
2011
2013	
2015	
2017	
2019	
2021	
2023
Non Scheme Products
Restricted Schemes
DHMS
2019 2020 2021 2022 2023	2019 2020 2021 2022 2023
Operating profit New business Non-scheme growth	Membership
+7% +19% >3.8m
to R3 854m to R8 678m Lives under
administration
Lives
>321k
Revenue
R1.5bn

-- 35 of 74 --

36
DHMS Rest of Industry
Gross lives Withdrawing lives
Solvency and reserves as at June 2023
Membership Customer satisfaction Solvency	Lapses
57.8% market share
Others
0%
1%
2%
3%
4%
Jan-19 Jan-20 Jan-21 Jan-22 Jan-23
Upgrade Downgrade
Less members are changing their
plans: R26.9bn
30.2%
AAA
0%
5%
10%
15%
20%
25%
30%
35%
40%
-
5
10
15
20
25
30
35
2019 2020 2021 2022 2023
Reserve Actual Solvency
Required Solvency
unaudited reserves
unaudited solvency
credit rating
R billion
~303k lives
Gross activations vs withdrawing
lives over the last 24 months, with
lapses remaining stable:
~284k lives
Left
employer
Affordability
Provider
change
Death
Emigration
Other
97%
No plan
changes
Awards recognising exceptional service:
Health Product Provider of
The Year
#1 ranked health insurer
amongst employers, providers
and brokers based on
independent survey results

-- 36 of 74 --

37
A change to Section 33 is required to enable
private sector collaboration
“33. Once National Health Insurance has been fully implemented as
determined by the Minister through regulations in the Gazette,
medical schemes may only offer complementary cover to services
not reimbursable by the Fund”
Status quo is unsustainable, universal healthcare is
crucial and NHI a remedy
Discovery’s position: NHI is not
workable without private sector
collaboration

-- 37 of 74 --

38
The private sector has significant scale And is delivering exceptional value for members
Outstanding
comprehensive cover,
with excellent outcomes
Meeting the highest
international standards
While remaining cost
effective in a challenging
environment
Achieved in a highly regulated
sector:
Guaranteed access to cover
Comprehensive prescribed
minimum benefits
Higher income
countries
South Africa
Cost of cover (PPP adjusted)
– 38%
86% 85%
56%
14%
Prostate Breast Colon Lung
High cancer survival rates
observed in the medical aid
population, in line best
health systems
>96%
cancer coverage for medical
scheme patients, as per CMS
research, including cover for
innovative, high-cost drugs
US Standard Discovery
Health
Readmission rates for over 65s
– 7%
83%
HbA1C testing rate for
diabetes patients – in line
with US benchmarks
Open Medical
Schemes
4.8m lives
Closed Medical
Schemes
4m lives
838
private facilities
42k
hospital beds
7.3k
GPs
47k
nurses
7k
specialists
3.5k
dentists
2.5k
optometrists
3.6k
psychologists
Community rated,
open to selection
Non-mandatory
membership

-- 38 of 74 --

39
However, funding the additional required spend through tax increases on a small base is not
sustainable
R200bn
Additional funding
required per annum, as
indicated by the National
Department of Health
31% increase in personal income tax or;
6.5% increase in VAT (from 15% to 21.5%) or;
10x increase in payroll tax (current UIF contributions).

-- 39 of 74 --

40
0
500
1000
1500
2000
2500
Current funding for uncovered lives With additional R200bn
For the population using the public sector For the medical scheme population
Healthcare funding available per person remains insubstantial:
R425ppm
R684ppm
0
500
1000
1500
2000
2500
Current private medical schemes Current NHI proposal
Significant reduction in healthcare funding:
R684ppm
R2 346ppm – 71%
While the rise in spend for South Africans using the
public sector is significant, the overall population’s
healthcare remains insubstantial at R684ppm
The medical scheme population will pay 31% more tax
and get 71% less healthcare, including a significant
portion of pensioners with the highest healthcare needs

-- 40 of 74 --

41
Countries with a private healthcare insurance market Countries without a private
healthcare insurance market
Afghanistan
Azerbaijan
Brunei Darussalam
Cook Islands
Cuba
Eritrea
Iceland
Iraq
Kiribati
Lesotho
Malta
Nauru
Niue
Norway
Papua New Guinea
Solomon Islands
Timor-Leste
17 countries	169 countries
In all countries listed, the absence of private
health insurance is attributable to market
dynamics, not a legislative ban
Algeria Central African Republic Gambia Lebanon Oman South Sudan
Andorra Chad Georgia Liberia Pakistan Spain
Angola Chile Germany Lithuania Palau Sri Lanka
Antigua and Barbuda China Ghana Luxembourg Panama Sudan
Argentina Colombia Greece Madagascar Paraguay Suriname
Armenia Comoros Grenada Malawi Peru Sweden
Australia Congo Guatemala Malaysia Philippines Switzerland
Austria Costa Rica Guinea Maldives Poland Tajikistan
Bahamas Côte d'Ivoire Guinea-Bissau Mali Portugal Thailand
Bahrain Croatia Guyana Marshall Islands Qatar Togo
Bangladesh Cyprus Haiti Mauritania Republic of Korea Tonga
Barbados Czechia Honduras Mauritius Republic of Moldova Trinidad & Tobago
Belarus DRC Hungary Mexico Romania Tunisia
Belgium Denmark India Micronesia Russian Federation Türkiye
Belize Djibouti Indonesia Monaco Rwanda Turkmenistan
Benin Dominica Iran Mongolia Saint Kitts and Nevis Tuvalu
Bhutan Dominican Republic Ireland Montenegro Saint Lucia Uganda
Bolivia Ecuador Israel Morocco Saint Vincent and the
Grenadines Ukraine
Bosnia & Herzegovina Egypt Italy Mozambique Samoa United Arab Emirates
Botswana El Salvador Jamaica Myanmar San Marino United Kingdom
Brazil Equatorial Guinea Japan Namibia Sao Tome and Principe United Republic of Tanzania
Bulgaria Estonia Jordan Nepal Senegal United States of America
Burkina Faso Eswatini Kazakhstan Netherlands Serbia Uruguay
Burundi Ethiopia Kenya New Zealand Seychelles Uzbekistan
Cabo Verde Fiji Kuwait Nicaragua Sierra Leone Vanuatu
Cambodia Finland Kyrgyzstan Niger Singapore Venezuela
Cameroon France Lao Nigeria Slovakia Vietnam
Canada Gabon Latvia North Macedonia Slovenia Zambia
Zimbabwe

-- 41 of 74 --

42
A change to Section 33 is required to enable
private sector collaboration
“33. Once National Health Insurance has been fully implemented as
determined by the Minister through regulations in the Gazette,
medical schemes may only offer complementary cover to services
not reimbursable by the Fund”
Status quo is unsustainable, universal healthcare is
crucial and NHI a remedy
Discovery’s position: NHI is not
workable without private sector
collaboration

-- 42 of 74 --

43
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 43 of 74 --

44
2023
Normalised
operating profit New business
Maintained leading
market share position
Strong capital
and liquidity
+19% +12%
to R4 807m to R2 838m
NMG Market Share survey Q2 2023
Quarter ending
June 2023
27.1%
30.2%
12 months to
June 2023
Group life returned
to profitability
Individual life: +8%
2019 2020 2021 2022 2023	2019 2020 2021 2022 2023
SCR
coverage
Liquidity
coverage
2023
188% R3 112m
1 X ILT
125%
SCR Target
Life and Invest
Strong cashflow
generation
Life and Invest cash flow
> 30% of net of tax
normalised earnings
Premium and Fees
Claims
Operational costs
Cashflows from
existing
New business strain
Net Finre
Net Cashflow
R2 125m
R4 934m
R19 523m

-- 44 of 74 --

45
Persistency
Mortality and morbidity
Premium and fee income
Policy alterations
Other
Total Non-Economic
Economic
Total
Life and Invest
Positive operating variances Strong EV growth
+8.1% RoEV
R275m
Discovery Life Ltd
variances (Rm)
Jun-22
New Business
Expected unwind incl New
Business
Experience Variances
Methodology and Assumption
Changes
Total before Economic Impact
Experience Variances
Methodology and Assumption
Changes
Components below the line
Jun-23
R38 433m R41 145m
R42 609m
Non-
economic
+11%
Economic
+7%
R1 064m
0%
20%
40%
60%
80%
100%
120%
H1 H2
Improvements in mortality
& morbidity experience vs H1
0%
1%
2%
3%
4%
5%
6%
7%
VNB margin
before
economic
and expense
impact
Economic Unit
expenses
June 23 net
VNB
5.7%
IRR above
RFR
2.54%
6.34%
VNB margin (%)
• Unit expense pressure, driven by affluent
protection market lagging pre-COVID
levels
• Initiatives to improve margins include
expense efficiency drive, driving growth
through product innovation and
adjacencies and growing the distribution
footprint
VNB margin impacted by
yield movements

-- 45 of 74 --

46
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 46 of 74 --

47
1 Shared-Value dynamics for the Single Premium Retirement annuity, five-year average
Normalised
operating profit New business
Assets under
administration
+30% +4% +15%
to R1 560m to R3 050m to R140bn
(R153bn including Umbrella Funds)
2019 2020 2021 2022 2023
Profit excl. once-offs Once-offs
+14% excl.
once-offs
-
20
40
60
80
100
120
140
160
Jul 2017	
Dec 2017	
May 2018	
Oct 2018	
Mar 2019	
Aug 2019	
Jan 2020	
Jun 2020	
Nov 2020	
Apr 2021	
Sep 2021	
Feb 2022	
Jul 2022	
Dec 2022	
May 2023
Linked Non-linked UF
2019 2020 2021 2022 2023
H1 H2
Positive dynamics from
Shared-value model
Withdrawal rates by boost
(relative to no boost)1
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
No boost Medium
boost
High boost
62%
lower

-- 47 of 74 --

48
Discovery Insure	
Discovery Life	
Discovery Invest	
Discovery Bank	
Discovery Health

-- 48 of 74 --

49
Gross written premium Gross new business
Normalised
operating profit	Vehicles insured
+10% +0% +138%	-2%
to R5.3bn to R1 249m to R62m	to 289 963
2018 2019 2020 2021 2022 2023 2018 2019 2020 2021 2022 2023	2018 2019 2020 2021 2022 2023	2018 2019 2020 2021 2022 2023

-- 49 of 74 --

50
50
60
70
80
90
100
110
120
130
H1 FY19	
H2 FY19	
H1 FY20	
H2 FY20	
H1 FY21	
H2 FY21	
H1 FY22	
H2 FY22	
H1 FY23	
H2 FY23
90
95
100
105
110
115
120
Q4 FY20
Q1 FY21	
Q2 FY21	
Q3 FY21	
Q4 FY21	
Q1 FY22	
Q2 FY22	
Q3 FY22	
Q4 FY22	
Q1 FY23	
Q2 FY23	
Q3 FY23	
Q4 FY23
Average accident cost per claim
Average motor premium
MTIs = mid-term increases
Recovered from COVID
under-pricing
Improvement in loss
ratio
Model leading to
positive dynamics
Margin continues to
recover
Total loss ratio (rebased) Operating profit margin	Average cost vs premium
(rebased)
100 89 73 66 57
Blue
Bronze
Silver	
Gold
Diamond
Loss ratio by status
(relative to blue)
MTIs	COVID Post-
MTIs
COVID	Pre-COVID MTIs
100 86 59 34 22
Blue
Bronze
Silver	
Gold
Diamond
Lapses by status
(relative to blue)
-10%
-8%
-6%
-4%
-2%
0%
2%
4%
6%
8%
H1
2021
H2
2021
H1
2022
H2
2022
H1
2023
H2
2023

-- 50 of 74 --

51
Vitality Health	
Vitality Life

-- 51 of 74 --

52
UK Composite
Normalised
operating profit Earned premiums New business	Lives covered
+14% +11% +19%	+11%
to £83.4m to £989.2m to £176m	to 1.72m lives
2019 2020 2021 2022 2023 2019 2020 2021 2022 2023
GBP millions	
GBP millions
2019 2020 2021 2022 2023 2019 2020 2021 2022 2023
GBP millions
Financial strength
and brand
Insurer Financial
Strength Rating of 'A’
Fitch ratings
UK financially self
sufficient, no further
funding needed from
Discovery
Source: H1 2023 Vitality Brand Survey, Immerse UK
Highest-ever brand
awareness since
inception
56 55 57 59 56 57 55 59 60 61 61 60 59 61
14 19 25 29 30 37
50 50 51 53 57 55 54 58
2014 2023
Promoted brand awareness
Competitor average vs Vitality

-- 52 of 74 --

53
2019 2020 2021 2022 2023 2019 2020 2021 2022 2023
VitalityHealth
Normalised
operating profit Earned premiums New business	Lives covered
-9% +11% +12%	+13%
to £59.9m to £623.6m to £96.3m	to 959k lives
GBP millions	
GBP millions	
GBP millions
2019 2020 2021 2022 2023	2019 2020 2021 2022 2023

-- 53 of 74 --

54
A changing healthcare landscape
Pressures in the NHS1
Increased demand for
health insurance
-
2,000,000
4,000,000
6,000,000
8,000,000
People on waiting list
Within 18 weeks 18-52 weeks > 1 year
NHS waiting lists at their highest
levels since pre-20072
1 Institute for Government: The NHS productivity puzzle, 2 NHS Digital, 3 Nuffield Trust: Quality Watch, 4 LaingBuisson Health Cover Report (18 Edition), 5 Including authorisations from additional out-of-hospital cover
6,200
6,400
6,600
6,800
7,000
7,200
7,400
7,600
7,800
8,000
2017 2018 2019 2020 2021 2022*
People covered by health
insurance4 (000)
*Estimate based on 2021 growth.
Challenges in accessing
care and treatment
Cancer waiting time target only
met once in 9 years3
0%
10%
20%
30%
40%
Oct-09	
Aug-10	
Jun-11	
Apr-12	
Feb-13	
Dec-13	
Oct-14	
Aug-15	
Jun-16	
Apr-17	
Feb-18	
Dec-18	
Oct-19	
Aug-20	
Jun-21	
Apr-22	
Feb-23
Patients waiting over 2 months for first
cancer treatment following referral
Lack of capital investment
The UK’s long-standing minimal
capital spend on health care relative
to other countries, where the
maintenance backlog has increased
to £10.75bn
Bed occupancy
Delayed discharges leave around
10% of the total number of beds –
equivalent to 20 hospitals – occupied
with patients who have no medical
need to be there but, usually, remain
there due to a lack of available care
outside the hospital system
Staff shortages
The NHS is operating with more
than 150,000 fewer full-time staff
than it needs
Experienced staff attrition
The leaver rate is at a record high of
12.5%
Increased utilisation
post-COVID
H2
2019
H2
2020
H2
2021
H2
2022
H2
2023
Authorisations per 1 000 lives
27% increase in
authorisations5
Target = 15%

-- 54 of 74 --

55
Vitality is transforming the role of health insurance
Moving from a supplementary product to holistic cover
The first insurer to offer
an end-to-end health
insurance claims
journey
56,000+ monthly visits to
Care Hub
40% authorisations
complete online
83% online mental health
bookings
71% online physio
bookings
Prioritising prevention
through the Vitality
programme
0%
10%
20%
30%
40%
50%
60%
Optical and dental module
Talking therapies
Phyiotherapy
Virtual GP
Expansive Primary Care
and the first insurer to
introduce Virtual GP
58% of claims
are for
Primary Care
Proven track record of
delivering superior
patient outcomes
-53%
-61%
-42%
-9%
Less
frequent
change of
consultant
(90 DAYS)
Length of
stay
Readmission
rates (28
DAYS)
Total
generated
spend
Non-Premier Premier
Premier Consultants
performance 2022
50%
60%
70%
80%
90%
100%
Musculoskeletal
Oncology
Cardiac
More activity	No activity
1 . LaingBuisson Health Cover report 18 Edition. Based on insured premiums only (excluding Trust)
* Estimated market growth based on LaingBuisson 2021 data
Driving significant growth
VitalityHealth is now the
3rd largest health insurer
by earned premium1
VitalityHealth and Market growth (lives)
2017-2022
+14%*
+60%
0%
10%
20%
30%
40%
50%
60%
70%
PMI market VitalityHealth
Vitality has grown at a 4x faster
rate than the market
In-hospital claims costs
and physical activity

-- 55 of 74 --

56
2019 2020 2021 2022 2023
VitalityLife
Normalised
operating profit Earned premiums New business	Lives covered
+47% +10% +30%	+9%
to £48.5m to £365.6m to £80.3m	to 765k lives
GBP millions	
GBP millions	
GBP millions
2019 2020 2021 2022 2023 2019 2020 2021 2022 2023	2019 2020 2021 2022 2023

-- 56 of 74 --

57
Outstanding new business growth supported by positive
experience variances
Outstanding growth in challenging market
conditions Positive lapse experience amid cost-of-living crisis
100
91
73 72 71
2018/19 2019/20 202/21 2021/22 2022/23
Annualised lapse rate
VitalityLife Market Share (IFA Channel)
Market (excl. VL) 5%
32%	VitalityLife
Annual sales growth (all channels)
GenRe, ProtectionPulse, June 2023
9%
10%
12%
13% 14% 14% 14%
15%
Q3 2021 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023
Market share

-- 57 of 74 --

58
Offsetting impacts from rise in interest rates
VNB margin materially impacted
by interest rates
High inflation driving in-force
premium increases
-2%
-1%
0%
1%
2%
3%
4%
VNB margin
before
economic
and expense
impact
Economic Unit
expenses
June 23 net
VNB
1.8%
IRR above
RFR
VNB margin (%)
• Economic impact was the biggest driver for the
reduction, both in terms of interest rate changes and
inflationary affect on unit costs
• However this was offset against higher premium
indexation on the in-force book, contributing to
profit growth
-1.02%
3.00%
0%
5%
10%
15%
90
95
100
105
110
115
Effective RPI
2
+13.7%
Effective premium
increase
In-force Indexed premium at July ’22
Indexation premium increases
Total in-force index-linked premiums
Indexation premium increases follow Retail Price Indexes (RPI) five months prior, capped at 10%
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
3.5%
4.0%
4.5%
5.0%
Jan
2016
Jan
2017
Jan
2018
Jan
2019
Jan
2020
Jan
2021
Jan
2022
Jan
2023
First hedge
and swaption
purchased
Hedges
moved onto
PAC book
Hedge
strategy
simplified
UK 25-year SONIA rate
Interest rates have
increased
Annual effective premium of Indexed
plans relative to July ‘22
£18m positive
operating profit impact

-- 58 of 74 --

59
USA

-- 59 of 74 --

60
Vitality Global
Vitality Global Operating result
FY19 FY20 FY21 FY22 FY23
Strong underlying growth, driven by deepened
partner relationships, broadening the reach of
Vitality assets and capabilities
Vitality
Network
Vitality Health
International
+49%
to $44m
+74%
to R777m
Vitality Network
Vitality Health International
USA
HEALTH

-- 60 of 74 --

61
Vitality Network
FY19 FY20 FY21 FY22 FY23
Integrated API by
insurance partners Revenue
Insurance partners
membership
FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23	FY19 FY20 FY21 FY22 FY23
Operating profit
-1%
to $1.4bn*
+16%
to R25.2bn
+3%
to $69.5m
+20%
to R1.2bn
+8%
to $23.1m
+26%
to R411m
+23%
to 3.7m

-- 61 of 74 --

62
Shared-Value insurance supporting positive outcomes for
our partner in the 4th largest life insurance market globally
Strong book growth driven by
increasing distribution force
High level of sustained
engagement
Positive actuarial dynamics driven by
Shared Value model
64%
70%
Engagement
% of members
earned a point
Penetration
Attachment rates
$1.3bn Vitality ANP
1.5m Policies sold
Relative
hospitalisation rates
Relative mortality
rates
Non-Vitality Vitality
18%
lower
Non-Vitality Vitality
43%
lower
Vitality ANP
2020 2021 2022 2023	2019

-- 62 of 74 --

63
Shared-Value insurance supporting positive outcomes for
our partner in the largest life insurance market globally
Source: Distribution of Vitality PLUS and Vitality PLUS not elected within the ‘Super Preferred’;
underwriting category for policies sold from 2017-2020. JH Vitality subset of members which
had successive data, 2019
2016 2017 2018 2019 2020 2021 2022
Election rate Healthy Outcomes
Annual Vitality Plus Sales Compared to the prior year, members reported
the following on their Vitality Health Check:
Improved Vitality PLUS election rates
Launch of Vitality on all
John Hancock products
36%
Average annual
growth rate
2016 2017 H1 H2 2019 2020 2021 2022
Launch of Vitality on all
John Hancock products
reported same or
better BMI
reported same or
better cholesterol
54%
reported same or
better diastolic
blood pressure
69% 82%
79% 66%
reported same
or better fasting
glucose
reported same or better
systolic blood pressure
Sales uplift
29
percentage
point
increase in
Vitality plus election
rates

-- 63 of 74 --

64
Key strategic focus areas
Vitality
Network
Vitality Health
International
1 Revenue growth through deepening of
existing insurance partnerships and
starting to participate in emerging
profits
2 Targeted pursuit of new insurance
partnerships, with a focus on expanding
in the US
3 Unlock geared profits through
operational efficiency and fixed
investment largely based in South
Africa
USA
HEALTH

-- 64 of 74 --

65
USA
+137%
to $22.6m
+177%
to R402m
Year of launch or
investment by VG
2020
2022
2009
2008
*section follows on
slide
HEALTH
+64%
to $55.5m
VHI excluding PAHI
FY19 FY20 FY21 FY22 FY23
VHI
 - Other
 
VHI
 – PAHI
Includes Amplify
Health revenue from
IP fees for health IP
Including PAHI equity earnings
VHI leverages the success of the mature PAHI to invest
into high potential health markets
Vitality Health International Revenue Operating result
FY19 FY20 FY21 FY22 FY23
Driven largely by
growth in PAHI

-- 65 of 74 --

66
VHI | Growth in high potential healthtech & insurance
ventures
USA
HEALTH
Health insurance
HealthTech
VUS continues to accelerate its development of the new personal pathways product with a
robust pipeline of sales prospects and strong market interest for the health solution
PAHI remains resilient and is supported by strong business fundamentals including a strong
balance sheet with a comprehensive solvency ratio of 267%
28m lives and 45% growth in operating profit
Digital health solutions have been established within Amplify Health, accelerated by the
acquisition of AiDA Technologies. Substantial progress has been made in the design,
specification and initial technology builds of 3 priority products
While revenue has declined due to the conclusion of COVID government contracts recovery
will be driven by new international contracts. One such opportunity is implementing a data
science platform with AI-driven personalised health recommendations for Vitality UK

-- 66 of 74 --

67
Emerging markets of focus
for Amplify Health
Key Amplify Health markets
(AIA Health TDA) Markets with AIA Vitality only
Product footprint
Committed:
• Private Medical
Insurance (PMI)
product builder
• Provider
management
consulting
Committed:
• Value, diagnostics,
insights
• Optical character
recognition (OCR)
• Fraud, Waste, &
Abuse (FWA) +
Pre-Auth
Committed:
• Health wallet
• AI Claims
• OCR
Pipeline:
• PMI product
builder
Committed:
• Data diagnostics
• OCR
• FWA
Pipeline:
• Chronic Disease
Management
(CDM)
Committed:
• Value insights
Committed:
• Value, diagnostics,
insights
Pipeline:
• FWA
• OCR
• Provider
Management
5 major products Broad footprint
Chronic disease
management (CDM)
Validates health risks and diagnosis, supports
self-management, and incentivises behaviour
modification
Vitality
Vitality identifies individuals’ health risks and
motivates and incentivises them to modify
relevant lifestyle behaviours to improve their
overall health and wellbeing
Provider management
Analytic tools for provider performance profiles,
alternative reimbursement models and network
modeling
Claims administration
End-to-end solution that automates claims,
improves cost control and enables better
insights from claims data
Fraud, waste, and abuse
AI based outlier detection and flagging
suspicious cases for assessors to review

-- 67 of 74 --

68
2019 2020 2021 2022 2023
PAHI licence Reinsurance
to RMB1.3bn
(RMB328m DSY’s
share)
2019 2020 2021 2022 2023	2019 2020 2021 2022 2023
Investment income and gains
Profit before investment income and
gains
1 100% of PAHI
Graphs and callouts on graphs are in Rands
PAHI’s operating
results pre-tax
Discovery’s operating
result after tax
PAHI licence New
business1Written premium1
+39% +76% -1%	+11%
to R3.4bn
(R849m DSY’s
share)
to R596m to R8.7bn	to R50.1bn
+12%
before
investment
income
+22%
PAHI licence
written premium
2019 2020 2021 2022 2023
+31% +2%
to RMB19.6bn
+63%
to RMB234m
-9%
to RMB3.4bn

-- 68 of 74 --

69
70%
78% 80% 83% 84%
2019 2020 2021 2022 2023
95% 100%
91% 92% 89%
2019 2020 2021 2022 2023
Assessments,
reports, and
actionable
recommendations
Effective
incentivised
wellness
management
programmes
Products and
services to support
positive health
outcomes
Successful pivot to a
health & wellness model
Robust core capabilities positively
impacting performance
Superior profit
margins
Growth in net asset
value
Net asset value
(RMBm)3
2022 profit margin2
1 Figures are for January to June for each financial year
2 Margins as reported by the different insurer’s in their Annual Financial Statements
3 100% of PAHI
Persistency1	Combined ratio1
4.8%
1.2% 1.2%
1.8%
1.0%
-
1 000
2 000
3 000
4 000
5 000
6 000
7 000
8 000
2020 2021 2022 2023

-- 69 of 74 --

70
0
100
200
300
400
500
600
700
800
900
Jan Feb Mar Apr May Jun
2022 2023
2022 2023
Low economic growth, decrease in PAL agents, and
COVID-19 impacted new business in last 2 years
Initial new business
slump recovered
New products and
growing channels
PAHI licence business (RMBm)	Number of existing PAL agents
New products launched
Growing alternative channels
YTD cumulative new
business change over FY
2023 (PAHI licence)
Red door sales impacted
by COVID-19 in 2023
Significant decrease in
number of PAL agents
Non-PAL new business (RMBm)
27%
lower
-9%
-25%
-20%
-15%
-10%
-5%
0%
Jul-2022
Aug-2022	
Sep-2022	
Oct-2022	
Nov-2022	
Dec-2022	
Jan-2023	
Feb-2023	
Mar-2023	
Apr-2023	
May-2023	
Jun-2023
0
100
200
300
400
500
600
700
800
900
2019 2020 2021 2022 2023
SuiShenYi channel
impacted by
legislative changes
in 21/22

-- 70 of 74 --

71
2022E 2025E 2030E
Poor Aspirant
Emerging MC Middle class
Upper MC Affulent
1 BCG; 2 United Nations; 3 Economic Intelligence Unit August 2023, 4 2023 National Bureau of Statistics: “China Statistical Yearbook” CHI=Commercial Health Insurance, SHI = Social Health Insurance, OOP = Out of Pocket
5 National Healthcare Security administration; 6: National Development and Reform Commission, China Banking and Insurance Regulatory Commission; 7: China Banking and Insurance News
Strong policy support
Percentage older than
65 to double by 2050
Middle class & affluent
to increase 80m by 2030
0
200
400
600
800
1 000
1 200
1 400
2022	
2024	
2026	
2028	
2030	
2032	
2034	
2036	
2038	
2040	
2042	
2044	
2046	
2048	
2050
<20 20-29
30-39 40-49
50-64 65 and above
Population by age band2 (m)	Population by income
bracket1 (m)
473 554
Policy commitment to public provision
of healthcare and Social Health
Insurance funding
National Healthcare Security Administration (NHSA)
recently reinforced commitment to expanding the
Social Health Insurance (SHI) provider network,
enhancing and standardising service agreements,
and improving reimbursement processes5
Policy commitment to private provision
and private funding, to complement
what is available in the public provider
sector and SHI
National Development and Reform Commission’s
14th Five-Year Plan for National Health emphasises
promoting the supply of private health insurance. A
joint announcement by 13 state departments
contemplates Commercial Health Insurance (CHI)
as a vital component of the healthcare system6
A progressive approach to ensuring
that the public and private sectors work
together, and do not bifurcate
The National Financial Regulatory Administration
and the NHSA are jointly working towards
information-sharing between CHI and SHI
information platforms. In June 2023, a draft
information-sharing protocol was released to
provincial Health Securities Administrations for
review and comment7
442 477 504 538 571 603
2022	
2023
E	
202
4E
2025
E
2026
E
2027
E
Healthcare expenditure
(USD bn)3
SHI, CHI, and OOP4
68% 67% 66% 64%
29% 28% 27% 27%
3% 5% 7% 9%
2018 2021 2024E 2027E
SHI OOP CHI
Healthcare insurance
increasingly important

-- 71 of 74 --

72
• Scaling the Bank to profit and positioning it as the face of the composite
• Ensuring each business is market leader in terms of market share, margin, product and customer value
• Scaling Ping An Health Insurance in a complex Chinese market
• Monetising and scaling IP in Vitality Network with key partners
• Globalising unique health assets
• Growing VitaltyHealth on the back of a complex NHS environment
• Using the Shared-Value Model to get superior ROC and growth in VitalityLife
• Integration of Life and Health
Perfect composite model, #1 in our chosen segments in every industry, and the Bank pivoting to growth as
the composite-maker within SA
A new generation life and health insurance composite, with integration at both a product and operational level
and a seamless One Vitality client journey
Leading wellness and healthcare platform that provides preeminent life and health insurers globally with our
Vitality shared-value and health management capabilities to assist them in making their customers healthier,
while ensuring their products are more competitive with better margins

-- 72 of 74 --

73
1
2
3
Growing quality earnings with a robust
balance sheet
A clear strategy per composite, intensifying
focus on key initiatives and ceasing those with
marginal benefits
4
+12%
New business
64%Cash
conversion
+24%Operating
profit
20%
FLR
10.6%
Investment in New
excl discontinued UK
Transitioning to IFRS 17
Evolving the Vitality Shared-Value Insurance
Model

-- 73 of 74 --

Discovery Group
Copyright 2023 Discovery Limited is the licensed controlling company of the designated Discovery Insurance Group. Registration number:
1999/007789/06.
Companies in the Group are licensed insurers and authorised financial services providers. 1 Discovery Place, Sandton, 2196 | www.discovery.co.za

-- 74 of 74 --